Literature DB >> 21035077

Delayed-onset retinal detachment after an intravitreal injection of ranibizumab for zone 1 plus retinopathy of prematurity.

Sun Young Jang1, Kyung Seek Choi, Sung Jin Lee.   

Abstract

Intravitreal injection of bevacizumab has been shown to satisfactorily treat retinopathy of prematurity; nevertheless, the safety of antivascular endothelial growth factor therapy in children remains uncertain. We report a patient with bilateral, zone 1, stage 3 plus retinopathy of prematurity who was treated with combined laser photocoagulation and intravitreal ranibizumab injection and demonstrated full regression at 3 months after injection but then developed bilateral retinal detachments 1 month later.
Copyright © 2010. Published by Mosby, Inc.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21035077     DOI： 10.1016/j.jaapos.2010.05.011

Source DB:  PubMed          Journal:  J AAPOS        ISSN： 1091-8531            Impact factor:   1.220


  22 in total

1.  Delayed onset atypical vitreoretinal traction band formation after an intravitreal injection of bevacizumab in stage 3 retinopathy of prematurity.

Authors:  B J Lee; J H Kim; H Heo; Y S Yu
Journal:  Eye (Lond)       Date:  2012-06-15       Impact factor: 3.775

Review 2.  Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity.

Authors:  Kay D Beharry; Gloria B Valencia; Douglas R Lazzaro; Jacob V Aranda
Journal:  Semin Perinatol       Date:  2016-01-29       Impact factor: 3.300

3.  [Pharmacological treatment for retinopathy of prematurity].

Authors:  A Stahl; H Agostini; C Jandeck; W Lagrèze
Journal:  Ophthalmologe       Date:  2011-08       Impact factor: 1.059

4.  Intravitreal injection of bevacizumab for retinopathy of prematurity.

Authors:  Kazuki Kuniyoshi; Koji Sugioka; Hiroyuki Sakuramoto; Shunji Kusaka; Norihisa Wada; Yoshikazu Shimomura
Journal:  Jpn J Ophthalmol       Date:  2014-02-26       Impact factor: 2.447

5.  Clinical Management of Recurrent Retinopathy of Prematurity after Intravitreal Bevacizumab Monotherapy.

Authors:  Helen A Mintz-Hittner; Megan M Geloneck; Alice Z Chuang
Journal:  Ophthalmology       Date:  2016-05-27       Impact factor: 12.079

6.  SiRNA silencing of VEGF, IGFs, and their receptors in human retinal microvascular endothelial cells.

Authors:  Yona Nicolau; Fayez Bany-Mohammed; Charles L Cai; Jacob V Aranda; Kay D Beharry
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

Review 7.  Paediatric retinal detachment: a review.

Authors:  Raffaele Nuzzi; Carlo Lavia; Roberta Spinetta
Journal:  Int J Ophthalmol       Date:  2017-10-18       Impact factor: 1.779

8.  Anti-secretogranin III therapy of oxygen-induced retinopathy with optimal safety.

Authors:  Fen Tang; Michelle E LeBlanc; Weiwen Wang; Dan Liang; Ping Chen; Tsung-Han Chou; Hong Tian; Wei Li
Journal:  Angiogenesis       Date:  2019-01-14       Impact factor: 9.596

9.  Adjunctive effect of intravitreal bevacizumab prior to lens-sparing vitrectomy in aggressive posterior retinopathy of prematurity: a case report.

Authors:  Hae Jung Sun; Kyung Seek Choi; Sung Jin Lee
Journal:  Jpn J Ophthalmol       Date:  2012-07-28       Impact factor: 2.447

Review 10.  [Guidelines for ophthalmological screening of premature infants in Germany (S2k level, AWMF guidelines register no. 024/010, March 2020) : Joint recommendation of the German Ophthalmological Society (DOG), Retinological Society (RG), Professional Association of Ophthalmologists in Germany e. V. (BVA), German Society of Paediatrics and Adolescent Medicine (DGKJ), Professional Association of Pediatricians (BVKJ), Federal Association "The Premature Child" , Society for Neonatology and Paediatric Intensive Care Medicine (GNPI)].

Authors:  Rolf F Maier; Helmut Hummler; Ulrich Kellner; Tim U Krohne; Burkhard Lawrenz; Birgit Lorenz; Barbara Mitschdörfer; Claudia Roll; Andreas Stahl
Journal:  Ophthalmologe       Date:  2021-03-10       Impact factor: 1.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.